GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results
February 25, 2021 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark ePlex® RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis
February 22, 2021 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that...
GenMark Diagnostics to Participate in the Cowen 41st Annual Health Care Conference
February 16, 2021 17:35 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing...
Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels
February 16, 2021 16:03 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today the...
L'étude souligne la valeur clinique potentielle des panels pour l'identification d'hémocultures ePlex®
February 16, 2021 16:03 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., 16 févr. 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ : GNMK), fournisseur de premier plan en matière de systèmes de tests de diagnostic moléculaire multiplex...
GenMark Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
February 11, 2021 16:17 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter and full year earnings results after market...
GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020
January 11, 2021 16:08 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...
GenMark Diagnostics to Participate in Upcoming Investor Conferences
December 28, 2020 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing...
GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum
November 05, 2020 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing...
GenMark Diagnostics Reports Third Quarter 2020 Results
October 28, 2020 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...